Japan, Sept. 14 -- NANTCELL INC has got intellectual property rights for 'MODIFIED T CELL RECEPTORS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS AND CANCER.' Other related details are as follows:

Application Number: JP,2025-086899

Category (FI): C12N15/62@Z,A61P37/04,C12N5/0783,A61K40/11,C12N15/12,C07K14/725,C12N5/10,A61P31/12,A61P35/00,A61K40/46,A61K40/42,A61K40/32,A61K40/15,C07K19/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: May 26, 2025

Publication Date: Aug. 26, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....